palmidrol has been researched along with 7,10,13,16-docosatetraenylethanolamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanus, L; Mechoulam, R; Sheskin, T; Slager, J; Vogel, Z | 1 |
| Burstein, S; Salmonsen, R | 1 |
2 other study(ies) available for palmidrol and 7,10,13,16-docosatetraenylethanolamide
| Article | Year |
|---|---|
Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor.
Topics: Amides; Animals; Arachidonic Acids; Brain; Endocannabinoids; Ethanolamines; Magnetic Resonance Spectroscopy; Molecular Structure; Polyunsaturated Alkamides; Protein Binding; Rats; Receptors, Cannabinoid; Receptors, Drug; Structure-Activity Relationship; Synaptosomes | 1997 |
Acylamido analogs of endocannabinoids selectively inhibit cancer cell proliferation.
Topics: Animals; Antineoplastic Agents; Cannabinoid Receptor Modulators; Cell Proliferation; Dopamine; Endocannabinoids; Fatty Acids, Unsaturated; Growth Inhibitors; HeLa Cells; Humans; Mice; Rats; Time Factors; Tumor Cells, Cultured; Tyrosine | 2008 |